Been watching Albemarle pretty closely lately, and there's something worth paying attention to here. The stock took a hit after earnings, down about 3% the morning after, but the bigger picture tells a different story.

Let me break down what caught my eye. Q4 revenue came in at $1.43 billion, beating expectations of $1.34 billion. More importantly, that's actual year-over-year growth - first time in four quarters. The company's earnings per share missed on the negative side at 53 cents, but here's the thing: that's still a 50%+ improvement compared to last year.

The real driver? Spodumene price movements have been wild. That key lithium ore has tripled since mid-2025 as supplies tightened. Spodumene price action is basically tracking the entire lithium supply-demand story right now.

What's really interesting is the demand side. Global lithium market is projected to explode from $32.38 billion in 2025 to $96.45 billion by 2033 - we're talking 14.5% compound annual growth. That's not a typo. EVs are driving a lot of it, but energy storage is becoming the sleeper play here.

Albemarle's management emphasized something important in their presentation: global stationary storage demand jumped over 80% in 2025. AI data centers are pulling massive amounts of power, and lithium-ion batteries are handling the load. Over 75% of global storage capacity relies on lithium. When you connect those dots, spodumene price trends matter because they signal whether supply can keep up.

On the production side, the company is being smart about it. They idled Kemerton Train 1 in Australia and shifted hydroxide output to cheaper Chilean brine operations. Keeps their spodumene access intact while managing costs. Domestically, that $90 million DOE grant for Kings Mountain is reshoring supply chain resilience - important move given Asia's current dominance.

Technically, ALB pulled back about 17% since late January, and there's definitely some momentum fatigue showing up. The 50-day moving average is sitting around $156.48, which would put the stock about 3% below current analyst targets. That's the zone patient bulls are watching.

The stock chart basically mirrors the lithium spot chart - both peaked in late 2022 when spodumene price hit nearly $80,000 per metric ton. Since then, it's been a tight correlation. Over the past year, ALB gained more than 110%, but the recent selloff has been deeper than typical dips.

Key question: does this hold support at the 50-day SMA, or do we see real distribution volume kick in? If spodumene price stabilizes and demand projections hold, the long-term setup looks solid. But short-term, this needs patience. The lithium story isn't going anywhere - demand fundamentals are too strong. Just might be a bumpy ride getting there.